FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 307:1037-1042 October 21, 1982 Number 17 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We evaluated protriptyline, a nonsedating tricyclic antidepressant, as a treatment for obstructive sleep apnea in a double-blind crossover study of five men. After two weeks of treatment, with no change in body weight, daytime somnolence was markedly reduced and nocturnal oxygenation was improved, although apnea duration and frequency were not significantly decreased. Rapid-eye-movement (REM) stage time as a fraction of the total sleep time was reduced during treatment from 0.231 +/- 0.031 to 0.107 +/- 0.013 (mean +/- S.E.M.) (P less than 0.05). REM apnea time as a fraction of total sleep time was reduced from 0.145 +/- 0.022 to 0.054 +/- 0.006 (P less than 0.05). REM reduction during treatment with protriptyline can account for decreased REM apnea time. Similar decreases in REM stage time and REM apnea duration and similar improvement in oxygenation continued after six months of treatment. In addition, body weight, apnea, and arousal frequency were decreased at this time. Although the obstructive sleep apnea was not resolved, it was reduced. Protriptyline can be effective in patients with sleep apnea when the disorder is not life-threatening.

This article has been cited by other articles:

• Jayaraman, G., Sharafkhaneh, H., Hirshkowitz, M., Sharafkhaneh, A. (2008). Review: Pharmacotherapy of obstructive sleep apnea. Ther Adv Respir Dis 2: 375-386 [Abstract]  
• Buyse, B., the participants of working group 2, (2007). Treatment effects of sleep apnoea: where are we now?. ERR 16: 146-168 [Abstract] [Full Text]  
• Ryan, C F (2005). Sleep {middle dot} 9: An approach to treatment of obstructive sleep apnoea/hypopnoea syndrome including upper airway surgery. Thorax 60: 595-604 [Abstract] [Full Text]  
• Schwartz, A. R., Bennett, M. L., Smith, P. L., De Backer, W., Hedner, J., Boudewyns, A., Van de Heyning, P., Ejnell, H., Hochban, W., Knaack, L., Podszus, T., Penzel, T., Peter, J. H., Goding, G. S., Erickson, D. J., Testerman, R., Ottenhoff, F., Eisele, D. W. (2001). Therapeutic Electrical Stimulation of the Hypoglossal Nerve in Obstructive Sleep Apnea. Arch Otolaryngol Head Neck Surg 127: 1216-1223 [Abstract] [Full Text]  
• HUDGEL, D. W., THANAKITCHARU, S. (1998). Pharmacologic Treatment of Sleep-disordered Breathing. Am. J. Respir. Crit. Care Med. 158: 691-699 [Abstract] [Full Text]  
• Phillipson, E. A. (1993). Sleep Apnea -- A Major Public Health Problem. NEJM 328: 1271-1273 [Full Text]  
• Moran, W. B., Orr, W. C. (1985). Diagnosis and Management of Obstructive Sleep Apnea: Part II. Arch Otolaryngol Head Neck Surg 111: 650-658 [Abstract]  
• Orr, W. C., Moran, W. B. (1985). Diagnosis and Management of Obstructive Sleep Apnea: A Multidisciplinary Approach. Arch Otolaryngol Head Neck Surg 111: 583-588 [Abstract]